DÍVIDA Alterar Data
Acadia Pharmaceuticals USD 73.85M 23.06M 2026-06
Adma Biologics USD 203.84M 567K 2026-06
ALKERMES USD 1.57B 10.58M 2026-09
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
AstraZeneca USD 32.24B 1.68B 2026-06
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Cipla INR 6.99B 857M 2026-09
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 3.02M 91K 2026-06
CSL USD 11.96B 219M 2024-12
Eli Lilly USD 54.91B 11.54B 2026-06
GlaxoSmithKline GBP 18.24B 818M 2026-06
Grifols EUR 9.23B 626.05M 2024-12
Halozyme Therapeutics USD 2.15B 2.02M 2026-06
Ionis Pharmaceuticals USD 1.77B 141M 2026-09
J&J USD 49.04B 5.95B 2026-06
Merck USD 53.91B 4.79B 2026-06
Minerva Neurosciences USD 0 0 2024-09
Neurocrine Biosciences USD 392.3M 9.5M 2026-09
Novartis USD 49.01B 2.02B 2026-06
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 62.67B 523M 2026-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
Takeda JPY 4.58T 364.32B 2026-09
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12